期刊文献+

尼可地尔对急诊PCI术后心肌梗死患者心肌微循环及预后的影响 被引量:1

Effect of Nicorandil on Myocardial Microcirculation and Prognosis in Patients with Myocardial Infarction after Emergency PCI
下载PDF
导出
摘要 目的:探讨尼可地尔对经皮冠状动脉介入治疗(PCI)术后心肌梗死患者心功能、心肌微循环的影响。方法:选取2018年1月~2019年1月本院收治的90例行急诊PCI术后心肌梗死患者,随机分为治疗组(45例)和对照组(45例)。对照组PCI术后予以常规治疗,治疗组在对照组基础上予以尼可地尔口服,两组均连续治疗6个月。比较两组心功能[左室射血分数(LVEF)、左室舒张末期内径(LVEDd)、血浆脑钠肽(BNP)]、TIMI血流分级、心肌微循环(血流速度、心肌血流量及毛细血管横截面积总和)、氧化应激及炎症指标[超氧化物歧化酶(SOD)、血清内皮素(ET)及超敏C反应蛋白(hs-CRP)]及主要心血管不良事件(MACE)发生情况。结果:治疗后,治疗组LVEF高于对照组(P<0.05),LVEDd、BNP低于对照组(P<0.05);TIMI血流分级优于对照组(P<0.05);血流速度、心肌血流量及毛细血管横截面积总和均大于对照组(P<0.05);SOD高于对照组(P<0.05),ET、hs-CRP低于对照组(P<0.05);治疗组MACE发生率(6.67%)与对照组(13.33%)比较无统计学差异(P>0.05)。结论:尼可地尔能够改善PCI术后心肌梗死患者心功能及心肌微循环,促进冠状动脉血流量灌注,改善预后。 Objective:To investigate the effects of nicorandil on cardiac function and myocardial microcirculation in patients with myocardial infarction after percutaneous coronary intervention(PCI).Methods:90 patients with myocardial infarction after emergency PCI in our hospital from January 2018 to January 2019 were randomly divided into treatment group(n=45)and control group(n=45).The control group was given routine treatment after PCI,and the treatment group was given nicorandil orally after PCI.Both groups were treated continuously for 6 months.Cardiac function[left ventricular ejection fraction(LVEF),left ventricular end-diastolic diameter(LVEDd),plasma brain natriuretic peptide(BNP)],TIMI blood flow grade,myocardial microcirculation(blood flow velocity,myocardial blood flow and total cross-sectional area of capillaries),oxidative stress and inflammatory indexes[superoxide dismutase(SOD),serum endothelin(ET)and high sensitivity C-reactive protein(hs-CRP)]and major adverse cardiovascular events(MACE)were compared between the two groups.Results:After the treatment,LVEF in the treatment group were significantly higher than that in the control group(P<0.05).And LVEDd,BNP in the treatment group were lower than those in the control group(P<0.05).The TIMI blood flow grade in the treatment group was significantly lower than that in the control group(P<0.05).The blood flow velocity,myocardial blood flow and the total cross-sectional area of capillaries in the treatment group were significantly higher than those in the control group(P<0.05).SOD in the treatment group was significantly higher than that in the control group(P<0.05),ET and hs-CRP were significantly lower in the treatment group than that in the control group(P<0.05).There was no significant difference in the incidence of MACE between the treatment group(6.67%)and the control group(13.33%)(P>0.05).Conclusion:Nicorandil can improve cardiac function and myocardial microcirculation,promote coronary blood flow perfusion and improve prognosis in patients with myocardial infarction after PCI.
作者 王同昂 华朋铎 张志锋 WANG Tong-ang;HUA Peng-duo;ZHANG Zhi-feng(Department of Cardiology,Nanyang Second General Hospital,Nanyang 473000,China;Department of Cardiology,Nanyang City Center Hospital,Nanyang 473000,China)
出处 《中国合理用药探索》 CAS 2020年第12期60-64,共5页 Chinese Journal of Rational Drug Use
关键词 尼可地尔 经皮冠状动脉介入 心肌梗死 心肌微循环 预后 nicorandil percutaneous coronary intervention myocardial infarction myocardial microcirculation prognosis
  • 相关文献

参考文献18

二级参考文献131

  • 1张健发,刘婕,黄定.PCI术中联合使用腺苷与盐酸替罗非班对老年急性ST段高型心肌梗死心肌微循环及心功能的影响[J].中国老年学杂志,2014,34(12):3231-3233. 被引量:34
  • 2HongCHEN,Xing-junWU,Xi-yuanLU,LiangZHU,Li-pingWANG,Huang-tianYANG,Hong-zhuanCHEN,Wen-junYUAN.Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats[J].Acta Pharmacologica Sinica,2005,26(7):806-812. 被引量:11
  • 3贾振华,李叶双,吴以岭,高怀林,陈静,谷春华,袁国强,吴相春,魏聪.急性心肌梗死证候诊断标准规范化研究[J].中国中西医结合急救杂志,2007,14(4):195-199. 被引量:53
  • 4TALHA S,BOUITBIR J,CHARLES A L, et aL Pretreatmentwith brain natriuretic peptide reduces skeletal musclemitochondrial dysfunction and oxidative stress after ischemia -reperfusion [J]. J Appl Physiol (1985),2013 , 114(2) : 172-179.
  • 5SHINODA N, HIRASHIKI A, OKUMURA T,et al. Predictivevalue of heart rate recovery after exercise testing in addition tobrain natriuretic peptide levels in ambulatory patients withnonischemic dilated cardiomyopathy [J]. Ann Noninvasive Electr-ocardiol, 2012, 17(4): 378-386.
  • 6CANTINOTTI M,STORTI S,LORENZONI V,et al. Thecombined use of neutrophil gelatinase—associated lipocalin andbrain natriuretic peptide improves risk stratification in pediatriccardiac surgery [ J ]. Clin Chem Lab Med, 2012,50(11):2009-2017.
  • 7DAVENPORT A. Changes in N-terminal pro-brain natriureticPeptide correlate with fluid volume changes assessed bybioimpedance in peritoneal dialysis patients [J]. Am J Nephrol,2012,36(4): 371-376.
  • 8NISHIKIMI T. Do plasma levels of brain natriuretic peptide(BNP) and N- terminal proBNP (NT-proBNP) increase indiastolic dysfunction as well as in systolic dysfunction. [J].Circ J, 2012, 76(11): 2540-2541.
  • 9BAERTS L, GOMEZ N, VANDERHEYDEN M, et al.Possible mechanisms for brain natriuretic peptide resistance inheart failure "with a focus on interspecies differences and canineBNP biology [J]. Vet J, 2012,194(1): 34-39.
  • 10DURAK-NALBANTIc A, D^UBUR A, DIUc M, et al. Brainnatriuretic peptide release in acute myocardial infarction [ J ].Bosn J Basic Med Sci, 2012,12(3) : 164-168.

共引文献5211

同被引文献15

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部